| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Cholecystokinin Analogue Ameliorates Cognitive Deficits and Regulates Mitochondrial Dynamics via the AMPK/Drp1 Pathway in APP/PS1 Mice
|
Hao, L.
|
|
|
|
2 |
p. 382-401
|
artikel
|
| 2 |
Adherence to the Mediterranean Diet Is not Related to Beta-Amyloid Deposition: Data from the Women’s Healthy Ageing Project
|
Hill, E.
|
|
2018
|
|
2 |
p. 137-141
|
artikel
|
| 3 |
Aducanumab: Appropriate Use Recommendations Update
|
Cummings, Jeffrey
|
|
|
|
2 |
p. 221-230
|
artikel
|
| 4 |
Aducanumab Trials EMERGE But Don’t ENGAGE
|
Schneider, Lon S.
|
|
|
|
2 |
p. 193-196
|
artikel
|
| 5 |
A Large Retrospective Cohort Study on the Risk of Alzheimer’s Disease and Related Dementias in Association with Vascular Diseases and Cancer Therapy in Men with Prostate Cancer
|
Du, Xianglin L.
|
|
|
|
2 |
p. 193-206
|
artikel
|
| 6 |
A Literature Review of Methodologies Used in Randomized Clinical Trials of Agitation in Alzheimer’s Disease
|
Dubé, Sanjay
|
|
2018
|
|
2 |
p. 120-133
|
artikel
|
| 7 |
Alzheimer’s Disease-Associated APOE ε4 Frequencies in Indian Population Genomes May Suggest Implications in Lecanemab Treatment
|
Jolly, B.
|
|
|
|
2 |
p. 525-526
|
artikel
|
| 8 |
Alzheimer’s Disease Biomarker Decision-Making among Patients with Mild Cognitive Impairment and Their Care Partners
|
Cox, Chelsea G.
|
|
|
|
2 |
p. 285-293
|
artikel
|
| 9 |
Alzheimer’s Disease Drug Development Pipeline 2020
|
Sabbagh, Marwan N.
|
|
|
|
2 |
p. 66-67
|
artikel
|
| 10 |
Alzheimer’s Disease Prevention Health Coaching
|
Rhodes, Annie
|
|
|
|
2 |
p. 277-285
|
artikel
|
| 11 |
A Machine Learning Framework for Assessment of Cognitive and Functional Impairments in Alzheimer’s Disease: Data Preprocessing and Analysis
|
Vinutha, N.
|
|
|
|
2 |
p. 87-94
|
artikel
|
| 12 |
Amnestic Mild Cognitive Impairment is Characterized by the Inability to Recover from Proactive Semantic Interference across Multiple Learning Trials
|
Loewenstein, David A.
|
|
|
|
2 |
p. 181-187
|
artikel
|
| 13 |
Amyloid and APOE Status of Screened Subjects in the Elenbecestat MissionAD Phase 3 Program
|
Roberts, Claire
|
|
|
|
2 |
p. 218-223
|
artikel
|
| 14 |
A Novel Computerized Cognitive Stress Test to Detect Mild Cognitive Impairment
|
Curiel Cid, Rosie E.
|
|
|
|
2 |
p. 135-141
|
artikel
|
| 15 |
Anti-Amyloid Therapies for Alzheimer’s Disease: An Alzheimer Europe Position Paper and Call to Action
|
Bradshaw, Angela C.
|
|
|
|
2 |
p. 265-273
|
artikel
|
| 16 |
Anxiety and Depressive Symptoms and Cortical Amyloid-β Burden in Cognitively Unimpaired Older Adults
|
Lewis, Catriona K.
|
|
|
|
2 |
p. 286-296
|
artikel
|
| 17 |
A Phase 1 Single-Ascending-Dose Trial in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravenous PNT001, a Novel Mid-domain Tau Antibody Targeting cis-pT231 Tau
|
Luca, Wendy
|
|
|
|
2 |
p. 366-374
|
artikel
|
| 18 |
A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer’s Disease
|
Schneider, L. S.
|
|
|
|
2 |
p. 247-254
|
artikel
|
| 19 |
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
|
Bock, J. R.
|
|
|
|
2 |
p. 123-126
|
artikel
|
| 20 |
A Pragmatic, Investigator-Driven Process for Disclosure of Amyloid PET Scan Results to ADNI-4 Research Participants
|
Erickson, C. M.
|
|
|
|
2 |
p. 294-302
|
artikel
|
| 21 |
Assessment of Clinical Meaningfulness of Endpoints in the Generation Program by the Insights to Model Alzheimer’s Progression in Real Life (iMAP) Study
|
Graf, Ana
|
|
2018
|
|
2 |
p. 85-89
|
artikel
|
| 22 |
A Web-Based Multidomain Lifestyle Intervention for Older Adults: The eMIND Randomized Controlled Trial
|
de Souto Barreto, Philipe
|
|
|
|
2 |
p. 142-150
|
artikel
|
| 23 |
Beyond Vision: A View from Eye to Alzheimer’s Disease and Dementia
|
Zheng, C.
|
|
|
|
2 |
p. 469-483
|
artikel
|
| 24 |
Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer’s Disease: A Comprehensive Review of the Colombian Kindred
|
Fuller, J. T.
|
|
2019
|
|
2 |
p. 112-120
|
artikel
|
| 25 |
Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer’s Disease Task Force
|
Cummings, Jeffrey
|
|
2018
|
|
2 |
p. 103-109
|
artikel
|
| 26 |
Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer’s Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions
|
García-Lluch, G.
|
|
|
|
2 |
p. 453-462
|
artikel
|
| 27 |
Chinese Version of the Baylor Profound Mental Status Examination: A Brief Staging Measure for Patients with Severe Alzheimer’s Disease
|
Fu, X.
|
|
|
|
2 |
p. 175-180
|
artikel
|
| 28 |
Chronic Pain in Multiple Sites and Dementia: A Vicious Cycle?
|
Tian, J.
|
|
|
|
2 |
p. 527-528
|
artikel
|
| 29 |
Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer’s Disease
|
Macedo, A. C.
|
|
|
|
2 |
p. 414-421
|
artikel
|
| 30 |
Cortical β-Amyloid in Older Adults Is Associated with Multidomain Interventions with and without Omega 3 Polyunsaturated Fatty Acid Supplementation
|
Hooper, Claudie
|
|
|
|
2 |
p. 128-134
|
artikel
|
| 31 |
Cost-Effectiveness of Dementia Prevention Interventions
|
McRae, Ian
|
|
|
|
2 |
p. 210-217
|
artikel
|
| 32 |
Cost-Effectiveness of Prevention for People at Risk for Dementia: A Scoping Review and Qualitative Synthesis
|
Braun, Alexander
|
|
|
|
2 |
p. 402-413
|
artikel
|
| 33 |
Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden
|
Bourgeat, Pierrick
|
|
|
|
2 |
p. 251-258
|
artikel
|
| 34 |
Cross-Sectional Characterization of Albumin Glycation State in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients
|
Costa, Montserrat
|
|
2018
|
|
2 |
p. 139-143
|
artikel
|
| 35 |
Cytomegalovirus Infection and Alzheimer’s Disease: A Meta-Analysis
|
Ji, Q.
|
|
|
|
2 |
p. 422-427
|
artikel
|
| 36 |
Data-Driven Participant Recruitment: Findings from the Alzheimer’s Disease Neuroimaging Initiative 3
|
Barger, Charissa
|
|
|
|
2 |
p. 122-127
|
artikel
|
| 37 |
Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer’s Disease Treated with Anti-Amyloid Beta Therapy
|
Barakos, Jerome
|
|
|
|
2 |
p. 211-220
|
artikel
|
| 38 |
Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer’s Disease
|
Burstein, A. H.
|
|
2018
|
|
2 |
p. 149-154
|
artikel
|
| 39 |
Diabetes Mellitus and Cognitive Decline – Prevention Should Not Be Delayed!
|
Sinclair, Alan J.
|
|
2018
|
|
2 |
p. 95-97
|
artikel
|
| 40 |
Digital Screening for Cognitive Impairment — A Proof of Concept Study
|
Bloniecki, Victor
|
|
|
|
2 |
p. 127-134
|
artikel
|
| 41 |
Digital Therapeutics for MCI and Alzheimer’s disease: A Regulatory Perspective — Highlights From The Clinical Trials on Alzheimer’s Disease conference (CTAD)
|
Shuren, J.
|
|
|
|
2 |
p. 236-240
|
artikel
|
| 42 |
Disease Burden and Attributable Risk Factors of Alzheimer’s Disease and Dementia in China from 1990 to 2019
|
Li, R.
|
|
|
|
2 |
p. 306-314
|
artikel
|
| 43 |
Does Tea Drinking Promote Health of Older Adults: Evidence from the China Health and Nutrition Survey
|
Wang, J.
|
|
|
|
2 |
p. 194-198
|
artikel
|
| 44 |
Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy Adults
|
Longhurst, Jason K.
|
|
|
|
2 |
p. 297-305
|
artikel
|
| 45 |
Effects of a Group-Based 8-Week Multicomponent Cognitive Training on Cognition, Mood and Activities of Daily Living among Healthy Older Adults: A One-Year Follow-Up of a Randomized Controlled Trial
|
Srisuwan, Patsri
|
|
|
|
2 |
p. 112-121
|
artikel
|
| 46 |
Effects of Rice Wine Lees on Cognitive Function in Community-Dwelling Physically Active Older Adults: A Pilot Randomized Controlled Trial
|
Nagai, Narumi
|
|
|
|
2 |
p. 95-103
|
artikel
|
| 47 |
Environmental Enrichment in Murine Models and Its Translation to Human Factors Improving Conditions in Alzheimer Disease
|
Colavitta, M. F.
|
|
|
|
2 |
p. 287-300
|
artikel
|
| 48 |
Ethical Considerations at the Intersection of Social Media and Dementia Prevention Research
|
Hrincu, V.
|
|
|
|
2 |
p. 274-284
|
artikel
|
| 49 |
Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer’s Disease Predementia
|
Souchet, B.
|
|
|
|
2 |
p. 338-347
|
artikel
|
| 50 |
Executive Function Predicts the Validity of Subjective Memory Complaints in Older Adults beyond Demographic, Emotional, and Clinical Factors
|
Chao, R.-Y.
|
|
|
|
2 |
p. 161-168
|
artikel
|
| 51 |
Exploring Factors that Contribute to Joining and Regularly Practicing in Cognitive Training among Healthy Older Adults: A One-Year Follow-Up Qualitative Study
|
Srisuwan, P.
|
|
|
|
2 |
p. 75-81
|
artikel
|
| 52 |
Exploring the Association between Amyloid-β and Memory Markers for Alzheimer’s Disease in Cognitively Unimpaired Older Adults
|
Parra, Mario A.
|
|
|
|
2 |
p. 339-347
|
artikel
|
| 53 |
Exploring the Associations between Alzheimer’s Disease and GBM Mediated by Microglia Based on Network Analysis
|
Zhang, Chunlong
|
|
|
|
2 |
p. 267-275
|
artikel
|
| 54 |
Factors Associated with Alzheimer’s Disease: An Overview of Reviews
|
Rochoy, Michaël
|
|
2019
|
|
2 |
p. 121-134
|
artikel
|
| 55 |
Feasibility of Using a Wearable Biosensor Device in Patients at Risk for Alzheimer’s Disease Dementia
|
Saif, N.
|
|
|
|
2 |
p. 104-111
|
artikel
|
| 56 |
Forecasting the Prevalence of Alzheimer’s Disease at Mild Cognitive Impairment and Mild Dementia Stages in France in 2022
|
Gabelle, Audrey
|
|
|
|
2 |
p. 259-266
|
artikel
|
| 57 |
Fructose Consumption is Associated with a Higher Risk of Dementia and Alzheimer’s Disease: A Prospective Cohort Study
|
Yan, J.
|
|
|
|
2 |
p. 186-192
|
artikel
|
| 58 |
Fruit Intake and Alzheimer’s Disease: Results from Mendelian Randomization
|
Liao, Wan-Zhe
|
|
|
|
2 |
p. 445-452
|
artikel
|
| 59 |
Health Economic Considerations in the Deployment of an Alzheimer’s Prevention Therapy
|
Mattke, Soeren
|
|
|
|
2 |
p. 303-309
|
artikel
|
| 60 |
Higher Cognitive Reserve Is Beneficial for Cognitive Performance Via Various Locus Coeruleus Functional Pathways in the Pre-Dementia Stage of Alzheimer’s Disease
|
Gong, Liang
|
|
|
|
2 |
p. 484-494
|
artikel
|
| 61 |
Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force
|
Sano, Mary
|
|
2018
|
|
2 |
p. 98-102
|
artikel
|
| 62 |
Identifying Dementia Risk in Older Veterans Using A Mailing Survey
|
Shah, A.
|
|
|
|
2 |
p. 371-375
|
artikel
|
| 63 |
Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Findings from a Longitudinal Cohort Analysis
|
Chandler, J.
|
|
|
|
2 |
p. 320-328
|
artikel
|
| 64 |
Implementing a Memory Clinic Model to Facilitate Recruitment into Early Phase Clinical Trials for Mild Cognitive Impairment and Alzheimer’s Disease
|
Park, Lovingly
|
|
2019
|
|
2 |
p. 135-138
|
artikel
|
| 65 |
Implications for BACE1 Inhibitor Clinical Trials: Adult Conditional BACE1 Knockout Mice Exhibit Axonal Organization Defects in the Hippocampus
|
Vassar, R.
|
|
2019
|
|
2 |
p. 78-84
|
artikel
|
| 66 |
Integrated Bioinformatic Analysis and Validation Identifies Immune Microenvironment-Related Potential Biomarkers in Alzheimer’s Disease
|
Yang, F.
|
|
|
|
2 |
p. 495-506
|
artikel
|
| 67 |
Integrated Care for Older People and the Implementation in the INSPIRE Care Cohort
|
Takeda, C.
|
|
|
|
2 |
p. 70-74
|
artikel
|
| 68 |
Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab
|
Mallinckrodt, C.
|
|
|
|
2 |
p. 171-177
|
artikel
|
| 69 |
Knowledge, Attitude and Preventive Practice on Dementia Care among Primary Health Professionals in Macao
|
Lo, I. L.
|
|
|
|
2 |
p. 83-86
|
artikel
|
| 70 |
Linking Geroscience and Integrated Care to Reinforce Prevention
|
Beard, J. R.
|
|
|
|
2 |
p. 68-69
|
artikel
|
| 71 |
Longitudinal Course of Agitation and Aggression in Patients with Alzheimer’s Disease in a Cohort study: Methods, Baseline and Longitudinal Results of the A3C Study
|
De Mauleon, Adelaide
|
|
|
|
2 |
p. 199-209
|
artikel
|
| 72 |
Longitudinal Exposure—Response Modeling of Multiple Indicators of Alzheimer’s Disease Progression
|
Polhamus, D. G.
|
|
|
|
2 |
p. 212-222
|
artikel
|
| 73 |
Medical and Psychiatric Risk Factors for Dementia in Veterans with and without Traumatic Brain Injury (TBI): A Nationwide Cohort Study
|
Gardner, Raquel C.
|
|
|
|
2 |
p. 244-250
|
artikel
|
| 74 |
Medical Journey of Patients with Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia: A Cross-sectional Survey of Patients, Care Partners, and Neurologists
|
Pruzin, Jeremy J.
|
|
|
|
2 |
p. 162-170
|
artikel
|
| 75 |
Memory for Semantically Related Objects Differentiates Cognitively Unimpaired Autosomal Dominant Mutation Carriers from Non-Carrier Family Members
|
Fox-Fuller, J. T.
|
|
|
|
2 |
p. 322-327
|
artikel
|
| 76 |
Mental Component Score (MCS) from Health-Related Quality of Life Predicts Incidence of Dementia in U.S. Males
|
Ding, Xiuhua
|
|
|
|
2 |
p. 169-174
|
artikel
|
| 77 |
Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease
|
Luo, J.
|
|
2018
|
|
2 |
p. 110-119
|
artikel
|
| 78 |
Molecular Subtyping of Mild Cognitive Impairment based on Genetic Polymorphism and Gene Expression
|
Li, H.-T.
|
|
|
|
2 |
p. 224-233
|
artikel
|
| 79 |
MRI Clinical Ratings and Cognitive Function in a Cross-Sectional Population Study of Dementia: The Cache County Memory Study
|
Tsui-Caldwell, Y. H. W.
|
|
2019
|
|
2 |
p. 100-107
|
artikel
|
| 80 |
Nanolithium, a New Treatment Approach to Alzheimer’s Disease: A Review of Existing Evidence and Clinical Perspectives
|
Guilliot, Solene
|
|
|
|
2 |
p. 428-434
|
artikel
|
| 81 |
Nanorobots the Future of Neurology: A Perspective on Alzheimer’s Disease
|
Hooper, Claudie
|
|
2018
|
|
2 |
p. 155-156
|
artikel
|
| 82 |
Nutrition-Based Approaches in Clinical Trials Targeting Cognitive Function: Highlights of the CTAD 2020
|
Giudici, Kelly Virecoulon
|
|
|
|
2 |
p. 118-122
|
artikel
|
| 83 |
Overtreating Alzheimer’s Disease
|
Canevelli, M.
|
|
|
|
2 |
p. 234-236
|
artikel
|
| 84 |
Personalized Computational Causal Modeling of the Alzheimer Disease Biomarker Cascade
|
Petrella, Jeffrey R.
|
|
|
|
2 |
p. 435-444
|
artikel
|
| 85 |
Plasma MMP-9 Levels as the Future Risk of Conversion to Dementia in ApoE4-Positive MCI Patients: Investigation Based on the Alzheimer’s Disease Neuroimaging Initiative Database
|
Abe, K.
|
|
|
|
2 |
p. 331-337
|
artikel
|
| 86 |
Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Estimates from Real-World Data
|
Chandler, J.
|
|
|
|
2 |
p. 310-319
|
artikel
|
| 87 |
Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator
|
Pang, Y.
|
|
|
|
2 |
p. 301-313
|
artikel
|
| 88 |
Predictive Utility of Plasma Amyloid and Tau for Cognitive Decline in Cognitively Normal Adults
|
Lee, Y.-J.
|
|
|
|
2 |
p. 178-185
|
artikel
|
| 89 |
Prevention of Alzheimer’s Disease in Chinese Populations: Status, Challenges and Directions
|
Feng, Lei
|
|
2018
|
|
2 |
p. 90-94
|
artikel
|
| 90 |
Psychometric Properties of the Clinical Dementia Rating — Sum of Boxes and other Cognitive and Functional Outcomes in a Prodromal Alzheimer’s Disease Population
|
McDougall, Fiona
|
|
|
|
2 |
p. 151-160
|
artikel
|
| 91 |
Public Policy Should Foster Alzheimer’s Treatment Availability: Comment on the Draft US Medicare Decision to Limit Payment for Aducanumab (Aduhelm™) to Patients Participating in Clinical Trials
|
Cummings, J.
|
|
|
|
2 |
p. 241-246
|
artikel
|
| 92 |
Report from the First Clinical Trials on Alzheimer’s Disease (CTAD) Asia-China 2018 : Bringing together Global Leaders
|
Chhetri, J. K.
|
|
2019
|
|
2 |
p. 144-147
|
artikel
|
| 93 |
Roles of Baseline Intrinsic Capacity and its Subdomains on the Overall Efficacy of Multidomain Intervention in Promoting Healthy Aging among Community-Dwelling Older Adults: Analysis from a Nationwide Cluster-Randomized Controlled Trial
|
Liang, C.-K.
|
|
|
|
2 |
p. 356-365
|
artikel
|
| 94 |
Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol
|
König, Alexandra
|
|
|
|
2 |
p. 314-321
|
artikel
|
| 95 |
Sensitivity of the Preclinical Alzheimer’s Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer’s Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial
|
Papp, Kathryn V.
|
|
|
|
2 |
p. 255-261
|
artikel
|
| 96 |
Shift in Hospitalizations for Alzheimer’s Disease to Related Dementias in France between 2007 and 2017
|
Rochoy, Michaël
|
|
2019
|
|
2 |
p. 108-111
|
artikel
|
| 97 |
Strong Relationship between Malnutrition and Cognitive Frailty in the Singapore Longitudinal Ageing Studies (SLAS-1 and SLAS-2)
|
Chye, L.
|
|
2017
|
|
2 |
p. 142-148
|
artikel
|
| 98 |
Study Protocol of a Comprehensive Activity Promotion Program for the Prevention of Dementia: A Randomized Controlled Trial Protocol
|
Shimada, Hiroyuki
|
|
|
|
2 |
p. 376-384
|
artikel
|
| 99 |
Sugar in Beverage and the Risk of Incident Dementia, Alzheimer’s disease and Stroke: A Prospective Cohort Study
|
Miao, Hongyun
|
|
|
|
2 |
p. 188-193
|
artikel
|
| 100 |
The ‘Aducanumab Story’: Will the Last Chapter Spell the End of the ‘Amyloid Hypothesis’ or Mark a New Beginning?
|
Khachaturian, Zaven S.
|
|
|
|
2 |
p. 190-192
|
artikel
|
| 101 |
The Association between Sugar-Sweetened Beverages and Cognitive Function in Middle-Aged and Older People: A Meta-Analysis
|
Sun, Q.
|
|
|
|
2 |
p. 323-330
|
artikel
|
| 102 |
The Association of Heart/Vascular Aging with Mild Cognitive Impairment in a Rural Multiethnic Cohort: The Project FRONTIER Study
|
Appiah, Duke
|
|
|
|
2 |
p. 315-322
|
artikel
|
| 103 |
The Effects of Dual-Task Training on Cognitive and Physical Functions in Older Adults with Cognitive Impairment; A Systematic Review and Meta-Analysis
|
Ali, N.
|
|
|
|
2 |
p. 359-370
|
artikel
|
| 104 |
The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer’s Prevention Registry
|
Lee, Athene K. W.
|
|
|
|
2 |
p. 152-161
|
artikel
|
| 105 |
The Geras Solutions Cognitive Test for Assessing Cognitive Impairment: Normative Data from a Population-Based Cohort
|
Bloniecki, Victor
|
|
|
|
2 |
p. 207-211
|
artikel
|
| 106 |
The Impact of Testosterone on Alzheimer’s Disease Are Mediated by Lipid Metabolism and Obesity: A Mendelian Randomization Study
|
Zhang, L.
|
|
|
|
2 |
p. 507-513
|
artikel
|
| 107 |
The Integrated Alzheimer’s Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial
|
Wessels, Alette M.
|
|
2018
|
|
2 |
p. 134-136
|
artikel
|
| 108 |
The MAPP Room Memory Test: Examining Contextual Memory Using a Novel Computerized Test in Cognitively-Unimpaired Individuals with Autosomal Dominant Alzheimer’s Disease
|
Giudicessi, A.
|
|
|
|
2 |
p. 463-468
|
artikel
|
| 109 |
Therapeutic Targets for Alzheimer’s Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force Report
|
Gauthier, Serge
|
|
|
|
2 |
p. 231-235
|
artikel
|
| 110 |
The Role of Thyroid Dysfunction in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
|
Salehipour, A.
|
|
|
|
2 |
p. 276-286
|
artikel
|
| 111 |
The Scottish Brain Health Service Model: Rationale and Scientific Basis for a National Care Pathway of Brain Health Services in Scotland
|
Ritchie, Craig W.
|
|
|
|
2 |
p. 348-358
|
artikel
|
| 112 |
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease
|
Budd Haeberlein, Samantha
|
|
|
|
2 |
p. 197-210
|
artikel
|
| 113 |
Unsupervised Online Paired Associates Learning Task from the Cambridge Neuropsychological Test Automated Battery (CANTAB®) in the Brain Health Registry
|
Ashford, Miriam T.
|
|
|
|
2 |
p. 514-524
|
artikel
|
| 114 |
Unsupervised Performance of the CogState Brief Battery in the Brain Health Registry: Implications for Detecting Cognitive Decline
|
Banh, T.
|
|
|
|
2 |
p. 262-268
|
artikel
|
| 115 |
Utility of Environmental Complexity as a Predictor of Alzheimer’s Disease Diagnosis: A Big-Data Machine Learning Approach
|
Yuan, M.
|
|
|
|
2 |
p. 223-235
|
artikel
|
| 116 |
Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer’s Disease
|
Reed, Catherine
|
|
2019
|
|
2 |
p. 90-99
|
artikel
|
| 117 |
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project
|
Malzbender, K.
|
|
|
|
2 |
p. 329-338
|
artikel
|
| 118 |
Validity of Normative Volumetric Estimates from Open Access Software in Amnestic Mild Cognitive Impairment
|
Fountain-Zaragoza, S.
|
|
|
|
2 |
p. 236-243
|
artikel
|
| 119 |
Validity of Online Versus In-Clinic Self-Reported Everyday Cognition Scale
|
Howell, Taylor
|
|
|
|
2 |
p. 269-276
|
artikel
|
| 120 |
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study
|
Padovani, Alessandro
|
|
|
|
2 |
p. 375-381
|
artikel
|
| 121 |
Where Do We Go from Here?
|
Petersen, Ronald C.
|
|
|
|
2 |
p. 188-189
|
artikel
|
| 122 |
Who Benefited the Most? Effectiveness of a Lifestyle Intervention Against Cognitive Decline in Older Women and Men – Secondary Analysis of the AgeWell.de-trial
|
Wittmann, Felix G.
|
|
|
|
2 |
p. 348-355
|
artikel
|
Tijdschrift beschrijving